X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (28) 28
index medicus (27) 27
clinical neurology (25) 25
humans (25) 25
neurosciences (21) 21
female (14) 14
adult (13) 13
immunology (12) 12
male (12) 12
neurology (11) 11
middle aged (9) 9
multiple-sclerosis (9) 9
experimental autoimmune encephalomyelitis (8) 8
animals (7) 7
killer cells (7) 7
magnetic resonance imaging (7) 7
nk cells (7) 7
allergy and immunology (6) 6
autoimmunity (6) 6
care and treatment (6) 6
immunosuppressive agents - therapeutic use (6) 6
patients (6) 6
research (6) 6
analysis (5) 5
clinical trials (5) 5
disability (5) 5
fingolimod (5) 5
marrow stromal cells (5) 5
multiple sclerosis - therapy (5) 5
multiple sclerosis, relapsing-remitting - drug therapy (5) 5
natalizumab (5) 5
stem cells (5) 5
young adult (5) 5
drug therapy (4) 4
functional recovery (4) 4
immunosuppressive agents - adverse effects (4) 4
medicine & public health (4) 4
mesenchymal stem cells (4) 4
mri (4) 4
multiple sclerosis - drug therapy (4) 4
multiple sclerosis - immunology (4) 4
natural killer cells (4) 4
natural-killer-cells (4) 4
neuroradiology (4) 4
nuclear magnetic resonance--nmr (4) 4
ophthalmology (4) 4
psychiatry (4) 4
risk factors (4) 4
t cells (4) 4
therapy (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
aged (3) 3
alemtuzumab (3) 3
amyotrophic-lateral-sclerosis (3) 3
article (3) 3
cd56bright nk cells (3) 3
cerebrospinal-fluid (3) 3
cohort studies (3) 3
diagnosis (3) 3
disease (3) 3
drugs (3) 3
follow-up studies (3) 3
health aspects (3) 3
immune response (3) 3
immune-response (3) 3
immunologic factors - adverse effects (3) 3
inflammation (3) 3
innate immune system (3) 3
interferon (3) 3
italy (3) 3
killer cells, natural - immunology (3) 3
lymphocytes (3) 3
mesenchymal stem cell transplantation - methods (3) 3
neurological diseases (3) 3
neuroprotection (3) 3
prevalence (3) 3
prognosis (3) 3
progressive multifocal leukoencephalopathy (3) 3
receptors (3) 3
research article (3) 3
retrospective studies (3) 3
risk (3) 3
studies (3) 3
adolescent (2) 2
autoimmune diseases (2) 2
bone-marrow (2) 2
brain - pathology (2) 2
cd4 t-cells (2) 2
cd56 (2) 2
cd56 nk cells (2) 2
cd56dim nk cells (2) 2
cell movement - immunology (2) 2
cell proliferation (2) 2
central-nervous-system (2) 2
demyelination (2) 2
dendritic cells (2) 2
diagnostic-criteria (2) 2
differentiation (2) 2
disability evaluation (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Multiple Sclerosis Journal, ISSN 1352-4585, 4/2019, Volume 25, Issue 4, pp. 510 - 512
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2017, Volume 16, Issue 4, pp. 252 - 253
  Baseline MRI activity is a major determinant of treatment choice, which should be adjusted for. [...]MRI activity might drive treatment switch, introducing... 
Neurology | DISABILITY | ALEMTUZUMAB | CLINICAL NEUROLOGY | Multiple Sclerosis | Humans | Immunosuppressive Agents | Drug therapy | Drug approval | Multiple sclerosis | Drugs | Studies | Pragmatism | Quality | Clinical trials | Interferon | Index Medicus
Journal Article
Journal Article
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, ISSN 1933-7213, 08/2019, pp. 1 - 8
Extending the natalizumab interval after the 24th administration could reduce the risk of progressive multifocal leukoencephalopathy (PML). The objective is to... 
Leukoencephalopathy | Progressive multifocal leukoencephalopathy | Index Medicus
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 8/2019, Volume 25, Issue 9, pp. 1263 - 1272
Background: With many options now available, first therapy choice is challenging in multiple sclerosis (MS) and depends mainly on neurologist and patient... 
relapsing–remitting | persistence | Switch | naïve | disease modifying therapies | real-life | relapsing-remitting | NATALIZUMAB | NEUROSCIENCES | ADHERENCE | CLINICAL NEUROLOGY | COMORBIDITIES | DRUGS | INJECTIONS | FINGOLIMOD | naive | Intolerance | Spinal cord | Multiple sclerosis | Demography | Copolymer 1 | Nuclear magnetic resonance--NMR | Magnetic resonance imaging | Decision making | Interferon | Patients | Index Medicus
Journal Article
Journal of Neurology, ISSN 0340-5354, 12/2018, Volume 265, Issue 12, pp. 2851 - 2860
Journal Article
Journal of Neurology, ISSN 0340-5354, 05/2018, Volume 265, Issue 5, pp. 1174 - 1183
Journal Article
BMC Neurology, ISSN 1471-2377, 04/2014, Volume 14, Issue 1, pp. 65 - 65
Journal Article